Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Thermo Scientific Mass Spec User Meetings

Published: Tuesday, October 15, 2013
Last Updated: Tuesday, October 15, 2013
Bookmark and Share
Guest presenters from Harvard Medical School, Stanford, Michigan State University, Pfizer and Bristol Meyers Squibb and other organizations will describe how they apply the latest high resolution accurate mass spectrometry technology to a variety of challenging life science experiments.

Oct. 22, 2013, Somerset, NJ.

• Wilhelm Haas, Massachusetts General Hospital: Transforming Protein Quantitation with Thermo Scientific Orbitrap Fusion Tribrid Mass Spectrometer
• Josh Coon, University of Wisconsin: NeuCode SILAC and Parallel Reaction Monitoring using the Orbitrap Fusion Tribrid MS
• Gavin Reid, Michigan State University: Mass Spec Strategies for Comprehensive Lipidome Analysis to Identify Lipid Biomarkers of Disease
• Jessy YY Fan, Pfizer: Quantification of Therpeutic Protein Targets using Immunoaffinity and High Resolution Mass Spectrometry
• David Pirman, Pfizer: Monitoring the Metabolic Fate of Biological Substrates by High Resolution Mass Spectrometry

October 22, 2013, Foster City, CA

• Shenheng Guan, University of California, San Francisco: Orbitrap-based Native Mass Spectrometry for Characterization of Large Intact Protein Complexes
• Livia Eberlin, Stanford University: Desorption of Electrospray Ionization Mass Spectrometry Imaging in Biomedical Research
• Christopher Adams, Stanford University: Current State of Structural Proteomics
• Dan McKemie, University of California, Davis: Analysis of Morphine and Morphine Metabolites

October 24,Cambridge, MA.

• Steve Gygi, Harvard Medical School: Transforming Protein Quantitation with Thermo Scientific Orbitrap Fusion Tribrid Mass Spectrometer
• Anna Merrill, University of Wisconsin: NeuCode SILAC and Parallel Reaction Monitoring using the Orbitrap Fusion Tribrid MS
• Jack Henion Quintiles: High Resolution MS for the Quantitative Determination of Guanfacine in Dried Plasma Spots Derived from Molecular Filtration of Whole Blood

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Fisher Scientific to Acquire Life Technologies Corporation
The definitive agreement will see Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share or approximately $13.6 billion.
Monday, April 15, 2013
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Using Drug-Susceptible Parasites to Fight Drug Resistance
Researchers at the University of Georgia have developed a model for evaluating a potential new strategy in the fight against drug-resistant diseases.
Boosting Breast Cancer Treatment
To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years.
How Cells ‘Climb’ to Build Fruit Fly Tracheas
Mipp1 protein helps cells sprout “fingers” for gripping.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos